HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Nab-Paclitaxel with platinum chemotherapy as sixth-line therapy for a non-small cell lung cancer patient].

Abstract
A 48-year-old woman was admitted to our hospital for sixth-line chemotherapy. A chest X-ray film and computed tomographic (CT) scan revealed a right-sided massive tumor with multiple lung tumors. Repeated treatment with carboplatin (AUC 6) on day 1 and nab-paclitaxel (100mg/m2) on days 1, 8, and 15, every 28 days were effective in this patient. Chemotherapy with nab-paclitaxel may be effective for patients with multi-recurrent adenocarcinoma.
AuthorsYoshihisa Ishiura, Yasutaka Shiba, Yasushi Terasaki, Yoshinobu Hinoue, Youichi Ishida, Masataka Segawa, Katsuhiko Saitoh, Norikazu Hirokami, Kazuo Kasahara, Masaki Fujimura
JournalGan to kagaku ryoho. Cancer & chemotherapy (Gan To Kagaku Ryoho) Vol. 42 Issue 4 Pg. 493-5 (Apr 2015) ISSN: 0385-0684 [Print] Japan
PMID25963700 (Publication Type: Case Reports, English Abstract, Journal Article)
Chemical References
  • 130-nm albumin-bound paclitaxel
  • Albumins
  • Carboplatin
  • Paclitaxel
Topics
  • Adenocarcinoma (drug therapy)
  • Albumins (administration & dosage)
  • Antineoplastic Combined Chemotherapy Protocols (therapeutic use)
  • Carboplatin (administration & dosage)
  • Carcinoma, Non-Small-Cell Lung (drug therapy)
  • Female
  • Humans
  • Lung Neoplasms (drug therapy, pathology)
  • Middle Aged
  • Paclitaxel (administration & dosage)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: